Page last updated: 2024-11-03

proadifen and Hyperglycemia

proadifen has been researched along with Hyperglycemia in 2 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Hyperglycemia: Abnormally high BLOOD GLUCOSE level.

Research Excerpts

ExcerptRelevanceReference
"ICRF-187, (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane, has been shown to protect against alloxan diabetes (el-Hage et al."3.67Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice. ( Crouch, RK; el-Hage, A; Ferrans, VJ; Herman, EH; Yang, GC, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wade, AE1
el-Hage, A1
Herman, EH1
Yang, GC1
Crouch, RK1
Ferrans, VJ1

Other Studies

2 other studies available for proadifen and Hyperglycemia

ArticleYear
Atropine antagonism of carbachol-induced hyperglycemia.
    Journal of pharmaceutical sciences, 1967, Volume: 56, Issue:8

    Topics: Animals; Atropine; Carbachol; Dogs; Drug Antagonism; Female; Hyperglycemia; Male; Proadifen; Rabbits

1967
Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice.
    Research communications in chemical pathology and pharmacology, 1986, Volume: 52, Issue:3

    Topics: Alloxan; Animals; Blood Glucose; Chelating Agents; Cimetidine; Diabetes Mellitus, Experimental; Dime

1986